AmCad BioMed vs PEC: monthly revenue

Monthly revenue and year-on-year change for AmCad BioMed (4188) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ AmCad BioMed ━ PEC

0%+108%-84%25/1026/0126/0426/0726/10

Monthly revenue history

MonthAmCad BioMedYoYPECYoY
Oct 2026NT$2.1 million-16.6%NT$2.84 billion+102.0%
Sep 2026NT$2.3 million-62.2%NT$2.64 billion+100.0%
Aug 2026NT$2.4 million+2.9%NT$2.62 billion+105.4%
Jul 2026NT$3.3 million+56.5%NT$2.51 billion+92.6%
Jun 2026NT$1.9 million-38.3%NT$2.33 billion+94.9%
May 2026NT$2.2 million-8.7%NT$2.46 billion+108.5%
Apr 2026NT$2.7 million-3.0%NT$2.06 billion+68.3%
Mar 2026NT$1.9 million-13.1%NT$1.94 billion+64.4%
Feb 2026NT$1.6 million-31.6%NT$1.6 billion+56.7%
Jan 2026NT$2.9 million+26.5%NT$1.58 billion+49.8%
Dec 2025NT$1.2 million-84.3%NT$1.92 billion+69.9%
Nov 2025NT$1.3 million-81.1%NT$1.55 billion+53.0%
Oct 2025NT$2.5 million-25.6%NT$1.4 billion+53.6%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16